Children 5 to 11

Pfizer asks Canada for 5-11s

October 19, 2021
Posted in

Pfizer yesterday asked Health Canada to approve its COVID-19 vaccine for children aged 5 to 11 years of age. The proposed doses are about one-third the size of those given to those 12 and up. To date, Pfizer has delivered over 46 million doses to Canada. Pfizer does note that…

Read More
Risk Sciences International 1

Antiviral treatment emergency use

October 11, 2021
Posted in ,

Merck announced today that it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form. Merck…

Read More
Risk Sciences International 2

A Merck pill?

October 1, 2021
Posted in ,

Merck has just announced an, as of now, pill-in-development to fight Covid-19. According to an internal Merck study, this pill has cut the risk of hospitalization or death from Covid-19 in half. If approved, this pill would become the first oral medicine to fight the viral infection for Covid-19. “At…

Read More
Pfizer logo

Booster shots approved by CDC

September 24, 2021
Posted in ,

Early this morning, the CDC followed the recommendations made by the Food and Drug Administration in the United States. The recommendation calls for patients over the age of 65, as well as those 18 to 65 that are immunocompromised what works in highly vulnerable professions or situations, to receive a…

Read More
Risk Sciences International 3

FDA approves Pfizer vaccine

August 23, 2021
Posted in ,

Today, the Pfizer-BioNTech COVID-19 vaccine won full approval by the U.S. Food and Drug Administration (FDA). The Pfizer vaccine thus becomes the first to be granted full approval by the U.S. drug regulator. Since December 2020, the two-dose vaccine had been operating with an emergency-use authorization. Today’s approval makes it…

Read More
Covid-19 booster shots

Boosters to come in the U.S.

August 18, 2021
Posted in ,

Today, in a joint statement, US health officials announced that booster doses of Covid-19 vaccines Moderna and Pfizer will be offered this fall, subject to authorization from the US Food and Drug Administration (FDA) and the go ahead from the US Centers for Disease Control and Prevention. “We are prepared…

Read More
Coronavirus

CDC: Delta is serious

July 30, 2021
Posted in ,

According to The Washington Post, and now confirmed by Director of the US Centers for Disease Control and Prevention (CDC), Dr. Rochelle Walensky, an internal CDC document reveals that the Delta Coronavirus variant appears to cause more severe illness than the initial strain of Covid-19 and spreads as easily and…

Read More
Tokyo Olympics logo

Olympic woes

July 20, 2021
Posted in

As the Tokyo Olympics are about to begin, Covid remains the headline. To date, three days before the opening ceremony, there have been 61 reported Covid cases casting a doubt over the testing protocols and the lack of vaccine enforcement for athletes and national delegations. Some fear that the virus,…

Read More
Covid Delta Variant

Delta variant in the news

July 12, 2021
Posted in

For several weeks, the Covid-19 headline has been the Delta Variant. Much discussion is focussed on the lasting vs. waning protection of the various vaccines. Today, 12 July 2021, Pfizer is set to speak with U.S. officials to try to convince them of the need for a booster shot. According…

Read More
World Health Organization (WHO) logo

WHO: Still wear masks

June 30, 2021
Posted in ,

The World Health Organization, WHO, advises that even the fully vaccinated continue to wear masks in light of the transmissibility of the new Delta Variant. According to Dr. Mariangela Simao, WHO Assistant Director-General for Access to Medicines and Health Products said: “People need to continue to use masks consistently, be…

Read More